China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on Inflammatory Markers for Predicting Outcomes of Immunotherapy in Lung Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130401
Registration Time: 2026/08/19
Type: Observational study
Primary Sponsor: Yuebei People’s Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338930
Published by HT Digital Content Services with permission from Health Daily Digest....